Compounding Jakobsohn’s concerns about Goodman were his complaints that the Knight CEO’s conservative strategy, which focused on providing loans and investing in venture capital, had not led …

More Knight Therapeutics CEO to remain on board, after all but one dissident withdraws candidacy Videos